These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33385575)

  • 1. Pharmacoinformatics based elucidation and designing of potential inhibitors against Plasmodium falciparum to target importin α/β mediated nuclear importation.
    Oany AR; Pervin T; Moni MA
    Infect Genet Evol; 2021 Mar; 88():104699. PubMed ID: 33385575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
    Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA
    Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study.
    Gupta S; Jadaun A; Kumar H; Raj U; Varadwaj PK; Rao AR
    J Biomol Struct Dyn; 2015; 33(11):2421-41. PubMed ID: 25967133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High throughput in silico identification and characterization of Plasmodium falciparum PRL phosphatase inhibitors.
    Pandey R; Kumar R; Gupta P; Mohmmed A; Tewari R; Malhotra P; Gupta D
    J Biomol Struct Dyn; 2018 Oct; 36(13):3531-3540. PubMed ID: 29039247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.
    Owoloye AJ; Ligali FC; Enejoh OA; Musa AZ; Aina O; Idowu ET; Oyebola KM
    PLoS One; 2022; 17(8):e0268269. PubMed ID: 36026508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in silico strategy for identification of novel drug targets against Plasmodium falciparum.
    Rout S; Patra NP; Mahapatra RK
    Parasitol Res; 2017 Sep; 116(9):2539-2559. PubMed ID: 28755265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational identification of Plasmodium falciparum RNA pseudouridylate synthase as a viable drug target, its physicochemical properties, 3D structure prediction and prediction of potential inhibitors.
    Afolabi R; Chinedu S; Ajamma Y; Adam Y; Koenig R; Adebiyi E
    Infect Genet Evol; 2022 Jan; 97():105194. PubMed ID: 34968763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
    Kalita J; Chetia D; Rudrapal M
    Med Chem; 2020; 16(7):928-937. PubMed ID: 31385774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.
    Himangini ; Pathak DP; Sharma V; Kumar S
    Bioorg Med Chem Lett; 2018 May; 28(9):1566-1569. PubMed ID: 29602682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling.
    Kosugi S; Hasebe M; Entani T; Takayama S; Tomita M; Yanagawa H
    Chem Biol; 2008 Sep; 15(9):940-9. PubMed ID: 18804031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the natural compound inhibitors against
    Manhas A; Kumar S; Jha PC
    J Biomol Struct Dyn; 2022 Jan; 40(1):31-43. PubMed ID: 32794426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysing the essential proteins set of Plasmodium falciparum PF3D7 for novel drug targets identification against malaria.
    Ali F; Wali H; Jan S; Zia A; Aslam M; Ahmad I; Afridi SG; Shams S; Khan A
    Malar J; 2021 Aug; 20(1):335. PubMed ID: 34344361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive Inhibition of Okanin against
    Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.